Intech Biopharm Corporation (6461)
TWSE
26.45
+2.40 (+9.98%)
Closed
Oct 2, 2026
Day's Range
24.0526.45
52 wk Range
22.7942.44
Financial Statements - 6461 - Intech Biopharm Corporation
Revenue
107.52M▲ 170.3%
Net Income
-389.03M▼ 5.7%Net Margin -361.8%
EBITDA
-257.44M▼ 4.4%
Free Cash Flow
-425.14M▼ 35.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 107.52M | 39.77M | 25.84M | 23.64M | 38.89M | 21.10M |
| Cost of Goods | 218.46M | 197.40M | 189.84M | 170.90M | 158.26M | 159.99M |
| Gross Profit | -110.94M | -157.62M | -163.99M | -147.26M | -119.37M | -138.89M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -364.50M | -356.12M | -320.46M | -318.08M | -293.98M | -240.56M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -382.22M | -368.20M | -337.98M | -327.87M | -301.75M | -250.37M |
| Income Tax | 6.80M | - | - | - | - | 0 |
| Net Income | -389.03M | -368.20M | -337.98M | -327.87M | -301.75M | -250.37M |
| EPS Basic | -2.57 | -2.635808 | -2.81 | -2.82 | -2.89409 | -2.436103 |
| EPS Diluted | -2.57 | -2.635808 | -2.81 | -2.82 | -2.89409 | -2.436103 |
| Basic Shares Outstanding | 151.66M | 139.58M | 120.46M | 116.13M | 104.40M | 103.51M |
| Diluted Shares Outstanding | 151.66M | 139.58M | 120.46M | 116.13M | 104.40M | 103.51M |
| Ebit | -348.70M | -334.04M | -304.39M | -304.83M | -282.21M | -233.55M |
| Ebitda | -257.44M | -246.69M | -219.58M | -219.48M | -196.92M | -148.61M |
| Net Income Continuous Operations | -382.22M | -368.20M | -337.98M | -327.87M | -301.75M | -250.37M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
